SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 580 filers reported holding SEAGEN INC in Q1 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,116,634 | +8.6% | 24,118 | -1.5% | 0.01% | +18.2% |
| Q2 2023 | $4,710,266 | -5.6% | 24,474 | -0.7% | 0.01% | -8.3% |
| Q1 2023 | $4,991,291 | +198.6% | 24,652 | +89.5% | 0.01% | +140.0% |
| Q4 2022 | $1,671,659 | +0.3% | 13,008 | +6.8% | 0.01% | 0.0% |
| Q3 2022 | $1,667,000 | -12.0% | 12,183 | +13.8% | 0.01% | -16.7% |
| Q2 2022 | $1,894,000 | +18.6% | 10,702 | -3.8% | 0.01% | +50.0% |
| Q1 2022 | $1,597,000 | -9.0% | 11,123 | -2.0% | 0.00% | 0.0% |
| Q4 2021 | $1,755,000 | -4.5% | 11,352 | +4.9% | 0.00% | 0.0% |
| Q3 2021 | $1,837,000 | +5.9% | 10,818 | -1.5% | 0.00% | 0.0% |
| Q2 2021 | $1,734,000 | -5.7% | 10,982 | -17.1% | 0.00% | 0.0% |
| Q1 2021 | $1,839,000 | -18.2% | 13,241 | +3.2% | 0.00% | -20.0% |
| Q4 2020 | $2,248,000 | – | 12,833 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |